Roche launches first Retina Summit with doctors, healthcare professionals We recently launched the first Roche Retina Summit with the theme “Oculus in Focus,” drawing around 40 retina specialists, doctors, experts, and healthcare professionals (HCPs) from around the country in a two-day session. Speaking at the event were: * Dr. Nancy Holekamp, Director of Retina Services at the Pepose Vision Institute in St. Louis, Missouri, USA, and Principal Global Medical Science Leader, Product Development Medical Affairs (PDMA) Ophthalmology, F. Hoffman - La Roche Ltd. * Dr. Jun Shyan Wong, Chief Executive Officer (CEO) of International Specialist Eye Center; Fellow of the Royal College of Surgeons in Edinburgh, UK; Fellow of the Vitreoretinal Surgery Fellowship in both Melbourne, Australia and Harvard, USA * Dr. Jeffrey Lim, current President of the Vitreo-Retina Society of the Philippines (VRSP); Member of the Philippine Board of Ophthalmology; Chairman of the Department of Ophthalmology, Chong Hua Hospital in Cebu; Director of the Eye Institute, Chong Hua Hospital; and Section Head of Retina, Vicente Sotto Memorial Medical Center in Cebu * Dr. Sherman Valero, Past President of both the VRSP and the Philippine Academy of Ophthalmology (PAO); Chairman, Department of Ophthalmology, Makati Medical Center; Consultant, American Eye Center; and Instructor, Ateneo School of Medicine. * Dr. Harvey Uy, Immediate Past President of the VRSP and past president of the PAO; Clinical Associate Professor, University of the Philippines College of Medicine; Research Associate Professor, National Institutes of Health; and currently Medical Director, Peregrine Eye and Laser Institute. “On behalf of Roche Philippines, I would like to express our deepest thanks for your commitment and resilience in joining us for this scientific discussion, despite the challenges that Typhoon Carina has brought upon all of us,” Dr. Diana Edralin, MD, DPCOM, Roche General Manager for Pharmaceuticals, said in her opening remarks. “Your dedication to our shared mission in bringing better care for patients with retinal diseases through this partnership and collaboration is truly inspiring,” Dr. Edralin told the doctors and HCPs present at the event. “With vision loss as a major global health problem, Roche will continue to pioneer clinical programs on diseases of the retina where the need is greatest. We have eight new molecular entities and one device for ophthalmology, and industry-leading 146 projects in the development pipeline, from first to third phase, across multiple disease categories,” she added. To ensure that people living with low vision will have timely and sustained access to diagnosis and treatment, Dr. Edralin said Roche has been working with the Philippine eyecare community “to improve its research capacity, generate real-world evidence, and hopefully, shape our healthcare system to minimize out-of-pocket spending.”
-
-
-
-
-
+4